Clinical Outcome Following Total Hip Arthroplasty With the SMF Stem

NCT02471703 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 126

Last updated 2021-02-21

No results posted yet for this study

Summary

This is a prospective, consecutive series, multicenter clinical study of clinical outcomes following total hip arthroplasty with the SMF stem.

Conditions

  • Joint Diseases

Interventions

DEVICE

Total hip arthroplasty

Total hip arthroplasty

Sponsors & Collaborators

  • Smith & Nephew, Inc.

    lead INDUSTRY

Principal Investigators

  • Sobia Parveen · Smith & Nephew, Inc.

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-27
Primary Completion
2020-02-01
Completion
2020-02-01

Countries

  • Belgium
  • Canada
  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02471703 on ClinicalTrials.gov